Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2010; 56(1): 30-40

THE ASSOCIATION OF -1082A→G POLYMORPHISM OF IL-10 AND (-308A→G) POLYMORPHISM OF TNFα GENES WITH BONE DENSITY IN ELDERLY WOMEN

І.М. Pishel, О.О. Yevtushenko, Yu.І. Leonov, N.V. Grygoryeva, Т.V. Orlyk, D.V.Shytikov, V.V. Povoroznyuk, G.М. Butenko.

    Institute of Gerontology of AMS of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz56.01.030


Abstract

We studied the association between disturbances of structure and function in bone tissue and (-1082A -> G) polymorphism of IL-10 and (-308A -> G) polymorphism of TNFб genes. SNP-polymerase cyclic reaction was used. The study failed to find significant influence of (-308A -> G) TNF6 polymorphism on the development of bone tissue pathology in postmenopausal women. The patients with AA genotype of -1082A/G IL-10 gene have significantly lower indices of bone density comparing with G allele carriers (GG/AG). This association remained true both for bone tissue density of whole body, and for sepa­rate parts of skeleton: lumbar spine, femur neck, Ward zone of hip bone. Our study indicates that (-308A -> G) polymorphism of TNFa gene is not associated with structural-functional changes in bone tissue in Ukrainian population. However, there is strong evidence that women who carries the AA geno­type of -1082A/G polymorphism of IL-10 gene have signifi­cantly lower bone tissue density. This indicates the potentialfor predictive genetic testing of osteoporosis risk. Analyses of gene combination IL-10 -1082G/G and TNFa -308G/G («anti­inflammatory genotype») did not show any significant asso­ciation of this genotype with bone tissue characteristics, which shows low predictive value of this combination for diagnos­tics of structural-functional state of bone tissue.

Keywords: gene polymorphisms, bone tissue, aging, IL-10,TNF

Full text: (PDF, in Ukrainian)

References

  1. Butenko GM Osteoporosis and the immune system . Problems of osteology. 1999. 2, N 3. P.23-28.
    2.  
  2. Bajnok E., Takacs I., Vargha P. et al. Lack of associa­tion between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women . Bone. 2000. 27,N 3. P.559-562. CrossRef  
  3. Bayley J.P., Ottenhoff T.H., Verweij C.L. Is there a future for TNF promoter polymorphisms . Genes Immun. 2004. 5, N 1. P.315-329. CrossRef PubMed
    4.  
  4. Bruunsgaard H., Pedersen B.K. Age-related inflam­matory cytokines and disease . Immunol. Allergy Clin. Nrth Am. 2003. 23, N 1. P.15-39. CrossRef  
  5. Chen H.Y., Chen W.C., Wu M.C. et al. Interleukin-1beta and interleukin-1 receptor antagonist gene poly­morphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporo­sis . Maturitas. 2002. 44, N 1. P.49-54. CrossRef  
  6. Duncan E.L., Brown M.A., Sinsheimer J. et al. Sugges­tive linkage of the parathyroid receptor type 1 to os­teoporosis . J. Bone Miner. Res. 1999. 14, N 12. P.1993-1999. CrossRef PubMed
    7.  
  7. Eisman J.A. Genetics of osteoporosis . Endocrine Rev. 2000. 20, N 6. P.788-804. CrossRef PubMed
    8.  
  8. Ferrari S.L., Ahn-Luong L., Garnero P. et al. Two pro­moter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women . J. Clin. Endocrinol. Metab. 2003. 88,N 1. P.255-259. CrossRef PubMed
    9.  
  9. Ferrari S.L., Garnero P., Emond S. et al. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women . Arthritis Rheum. 2001. 44, N 1. P.196-201. CrossRef  
  10. Fowler E., Eri R., Hume G. et al. TNF{alpha} and IL10 SNPs act together to predict disease behaviour in Crohn's disease . J. Med. Genetics. 2005. 42, N 2. P.523-528. CrossRef PubMed PubMedCentral
    11.  
  11. Gallagher P.M., Lowe G., Fitzgerald T. et al. Associa­tion of IL-10 polymorphism with severity of illness in community acquired pneumonia . Thorax. 2003. 58,N 1. P.154-156. CrossRef PubMed PubMedCentral
    12.  
  12. Giacconi R., Cipriano C, Albanese F.C.A. The 174G. C polimorphism of IL-6 is useful to screen old sub- jects at risk for atherosclerosis or to reach successful ageing . Exp. Gerontol. 2004. 39, N 4. P.621-628. CrossRef PubMed
    13.  
  13. Ginaldi L., De Martinis M., Monti D., Franceschi C. Chronic antigenic load and apoptosis in immuno-senescence . Trends Immunol. 2005. 26, N 1. P.79-84. CrossRef PubMed
    14.  
  14. Ginaldi L., DiBenedetto M.C, DeMartinis M. Os­teoporosis, inflammation and aging . Immunity & Age­ing. 2005. 2, N 1. P.14-27. CrossRef PubMed PubMedCentral
    15.  
  15. Gong M.N., Thompson B.T., Williams P.L. et al. Interleukin-10 polymorphism in position 1082 and acute respiratory distress syndrome . Eur. Respir. J. 2006. 27,N 3. P.674-681. CrossRef PubMed PubMedCentral
    16.  
  16. Gonzalez S., Rodrigo L., Martinez-Borra J. et al. TNF-a-308A promoter polymorphism is associated with enhanced TNF-a production and inflammatory activ­ity in Crohn's patients with fistulizing disease . Amer. J. Gastroenterol. 2003. 98, N 1. P.1101-1111. CrossRef PubMed
    17.  
  17. Haider A.S., Lowes M.A., Su6rez-Faricas M. et al. Iden­tification of cellular pathways of «Type 1,» Th17 T cells, and TNF- and inducible Nitric Oxide Synthase-produc-ing dendritic cells in autoimmune inflammation through pharmacogenomic study of Cyclosporine A in psoriasis . J. Immunol. 2008. 180, N 3. P.1913-1920. CrossRef PubMed
    18.  
  18. Hajeer A.H., Hutchinson I. Influence of TNF-b gene polymorphisms on TNF-a production and disease . Hum. Immunol. 2001. 62, N 4. P.1191-1199.
    19. CrossRef  
  19. Hirose K., Tomiyama H., Okazaki R. et al. Increased pulse wavevelocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia . J. Clin. Endocrinol. Metab. 2003. 88, N 6. P.2573-2578. CrossRef PubMed
    20.  
  20. Hofbauer L.C., Gori F., Riggs B.L. et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of gluco-corticoid-induced osteoporosis . Endocrinology. 1999. 140,N 5. P.4382-4389. CrossRef PubMed
    21.  
  21. Katagiri T., Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation . Oral. Dis. 2002. 8,N 1. P.147-159. CrossRef PubMed
    22.  
  22. Krishnamurthy P., Rajasingh J., Lambers E. et al. IL-10 Inhibits inflammation and attenuates left ventricu­lar remodeling after myocardial infarction via activa­tion of STAT3 and suppression of HuR . Circulat. Res. 2009. 104, N 1. P.e9 e18. CrossRef PubMed PubMedCentral
    23.  
  23. Langdahl B.L., Knudsen J.Y., Jensen H.K. et al. A se­quence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and in­creased bone turnover in both osteoporotic and normal women . Bone. 1997. 20, N 1. P.289-294. CrossRef  
  24. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis . Endo­crine Rev. 2000. 21, N 2. P.115-137.25. Manolagas S.C., Weinstein R.S. New developments in the pathogenesis and treatment of steroid-induced os­teoporosis . J. Bone Miner. Res. 1999. 14, N 6. P.1061-1066. CrossRef PubMed
    25.  
  25. Mencej S., Albagha O.M.E., Janez Preelj. et al. Tu­mour necrosis factor superfamily member 11 gene pro­moter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis . J. Mol. Endocrin. 2008. 40,N 1. P.273-279. CrossRef PubMed
    26.  
  26. Moffett S.P., Zmuda J.M., Oakley J.I. et al. Tumor necro­sis factor-a polymorphism, bone strength phenotypes, and the risk of fracture in older women . J. Clin. Endocrin. & Metabol. 2005. 90, N . 6. P.3491-3497. CrossRef PubMed
    27.  
  27. Monneret G., Finck M.E., Venet F. et al. The anti­inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration . Immunol. Lett. 2004. 95,N 1. P.193-198. CrossRef PubMed
    28.  
  28. Nanes M.S. Tumor necrosis factor- b molecular and cellular mechanisms in skeletal pathology . Gene. 2003. 321,N 1. P.1 15. CrossRef  
  29. Oberholzer A., Oberholzer C, Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syn­dromes and its potential as an anti-inflammatory drug . Crit. Care. Med. 2002. 30, N 1. P. S58-S63. CrossRef  
  30. Ota N., Hunt S.C., Nakajima T. et al. Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib pair analysis . Genes. Immun. 2000. 1, N 4. P.260-264. CrossRef PubMed
    31.  
  31. Owens J.M., Gallagher A.C., Chambers T.J. IL-10 modu­lates formation of osteoclasts in murine hemopoietic cultures . J. Immunol. 1996. 157, N 2. P.936-945.
    32.  
  32. Palmeri S., Lio D., Vaglica M. et al. Caruso Analysis of interleukin 10 (IL-10)-1082G. A single nucleotide poly­morphism (SNP) genotypes in breast cancer (BC) pa­tients (pts) and in >95 years old cancer free women . J. Clin. Oncol. 2005. 23, S 16. P.9656-9664. CrossRef  
  33. Poli , Balena R., Fattori E. et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion . EMBO J. 1994. 13, N 10. P.1189-1196. CrossRef PubMed PubMedCentral
    34.  
  34. Prevention and management of osteoporosis. WHO: Geneva, 2003. 192 p.
    35.  
  35. Ralston S.H. Genetic control of susceptibility to os­teoporosis . J. Clin. Endocrinol. Metab. 2002. 87, N 6. P.2460-2466. CrossRef  
  36. Reuss E., Fimmers R., Kruger A. et al. Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study . Genes Immunol. 2002. 3,N 2. P.407-413. CrossRef PubMed
    37.  
  37. Roubenoff R. Catabolism of aging: is it an inflammatory process . Curr. Opin.Clin. Nutr. Metab. Care. 2003. 6,N 1. P.295-299. CrossRef  
  38. Sasaki H., Hou L., Belani A. et al. IL-10, but N t IL-4, suppresses infection-stimulated bone resorption in vivo . J. Immunol. 2000. 165, N 9. P.3626-3630. CrossRef PubMed
    39.  
  39. Schulte C.M., Dignass A.U., Goebell H. et al. Genetic factors determine extent of bone loss in inflammatory bowel disease . Gestroenterology. 2000. 119, N 4. P.909-1020. CrossRef PubMed
    40.  
  40. Seeman E. Physiology of aging invited review: Patho­genesis of osteoporosis . J. Appl. Physiol. 2003. 95,N 12. P.2142-2151. CrossRef PubMed
    41.  
  41. Shi X.M., Chang Z.J., Blair H.C. et al. Glucocorti­coids induce adipogenesis of stromal cells by tran­scriptionally activating PPARy2 . Bone. 1998. 23, S6. P.S454-S462.
    42.  
  42. Suarez A., Castro P., Alonso R. et al. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with ge­netic polymorphisms . Transplantation. 2003. 75, N 3. P.711-717. CrossRef PubMed
    43.  
  43. Takacs I., Koller DL., Peacock M. et al. Sib pair link­age and association studies between bone mineral den­sity and the interleukin-6 gene locus . Bone. 2000. 27,N 1. P.169-173. CrossRef  
  44. Wallin R., Wajih N., Greenwood G.T., Sane D.C. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy . Med. Res. Re 2001. 21,N 1. P.274-301. CrossRef PubMed
    45.  
  45. Weitzmann M.N., Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale . J. Clin. Invest. 2006. 116, N 4. P.1186-1194. CrossRef PubMed PubMedCentral
    46.  
  46. Yun A.J., Lee P.Y. Maladaptation of the link between inflammation and bone turnover may be a key determi­nant of osteoporosis . Med. Hypotheses. 2004. 63, N 2. P.532-537. CrossRef

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.